Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of March 2023, specifically dated March 23, 2023. The document serves as a notification of transactions by a Person Discharging Managerial Responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics for the company. The only financial data provided relates to a specific executive share transaction:
- Shares Exercised: 971,802 ordinary shares under the 2013 Performance Share Plan.
- Shares Sold: 457,308 shares sold to cover tax and national insurance liabilities.
- Transaction Price: 559.8605p per share.
- Total Sale Proceeds: £2,560,286.86.
Material Changes
The filing reports a change in the shareholding of Andy Ransom, Chief Executive. He exercised awards granted in April and October 2013 which vested in 2016 and were set to lapse if unexercised. Approximately 47% of the exercised shares were immediately sold on the London Stock Exchange to satisfy tax obligations.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It is strictly a regulatory disclosure of an insider transaction.
Investor Verification Checklist
- Verify the total number of shares held by Andy Ransom post-transaction to assess remaining insider exposure.
- Confirm the vesting schedule and expiration dates for any remaining unexercised awards under the 2013 Performance Share Plan.
- Review the company's most recent Form 20-F or annual report for consolidated financial performance, as this 6-K does not provide such data.